[1]
Chudiwal, T.B. and Sharma, I.O. 2016. Lixisenatide: a once-daily glucagon-like peptide-1 receptor agonist. International Journal of Basic & Clinical Pharmacology. 5, 6 (Dec. 2016), 2311–2320. DOI:https://doi.org/10.18203/2319-2003.ijbcp20164085.